Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment ; volume:9 ; number:02 ; year:2017 ; pages:136-139
Journal of laboratory physicians ; 9, Heft 02 (2017), 136-139

Contributor: Shah, Neha
Ray, Jay Gopal
Kundu, Sanchita
Sardana, Divesh

DOI: 10.4103/0974-2727.199622

URN: urn:nbn:de:101:1-2020041708335555547295

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:53 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Shah, Neha
Ray, Jay Gopal
Kundu, Sanchita
Sardana, Divesh

Other Objects (12)

$Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient$

Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient

Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis

Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern

Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis

Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis

Hospital use of systemic antifungal drugs

Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis

Myeloid cell deficiency of p38γ/p38δ protects against candidiasis and regulates antifungal immunity

Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model

Plumieride as a novel anti-fungal and anti-inflammatory iridoid against superficial candidiasis in mice

Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis

$Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient$

Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient

Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis

Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern

Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis

Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis

Hospital use of systemic antifungal drugs

Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis

Myeloid cell deficiency of p38γ/p38δ protects against candidiasis and regulates antifungal immunity

Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model

Plumieride as a novel anti-fungal and anti-inflammatory iridoid against superficial candidiasis in mice

Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis

$Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient$

Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient

Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis

Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern

Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis

Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis

Hospital use of systemic antifungal drugs

Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis

Myeloid cell deficiency of p38γ/p38δ protects against candidiasis and regulates antifungal immunity

Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model

Plumieride as a novel anti-fungal and anti-inflammatory iridoid against superficial candidiasis in mice

Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient

Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis

Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern

Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis

Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis

Hospital use of systemic antifungal drugs

Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis

Myeloid cell deficiency of p38γ/p38δ protects against candidiasis and regulates antifungal immunity

Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model

Plumieride as a novel anti-fungal and anti-inflammatory iridoid against superficial candidiasis in mice

Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis

Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient

Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis

Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern

Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis

Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis

Hospital use of systemic antifungal drugs

Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis

Myeloid cell deficiency of p38γ/p38δ protects against candidiasis and regulates antifungal immunity

Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model

Plumieride as a novel anti-fungal and anti-inflammatory iridoid against superficial candidiasis in mice

Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis

Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient

Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis

Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern

Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis

Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis

Hospital use of systemic antifungal drugs

Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis

Myeloid cell deficiency of p38γ/p38δ protects against candidiasis and regulates antifungal immunity

Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model

Plumieride as a novel anti-fungal and anti-inflammatory iridoid against superficial candidiasis in mice

Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis

Related objects

Reset password